June 2, 2018: Two Big Ten Cancer Research Consortium studies were accepted as abstracts to the American Society of Clinical Oncology (ASCO) Annual Meeting, June 1-5, 2018, at the McCormick Place in Chicago. The BTCRC-GU14-003 study was presented during a poster session on Saturday, June 2, while the BTCRC-ESO14-012 study was accepted for publication. Arkadiusz Dudek, MD, PhD (left), is sponsor-investigator of BTCRC-GU14-003, and Shadia Jalal, MD, is sponsor-investigator of BTCRC-ESO14-012. BTCRC-GU14-003 was the Big Ten CRC's first study to open to accrual, and completed enrollment about six months ahead of schedule. Read More
May 21, 2018: On your MARK, get SET, GO Across the Consortium! Get up to date on recent clinical trial outcomes; big leaps in funding; and diagnostic breakthroughs with far-reaching implications. Be inspired by the Big Ten CRC Member Institutions as you witness researchers tackling the toughest questions in oncology as a team. Read More
May 12, 2018: Investigator Spotlight Monika Joshi, MD, MRCP, Penn State Cancer Institute Educational Background MB, BS, Kasturba Medical College, Manipal Academy of Higher Education Member of Royal College of Physicians, London MD Residency, Internal Medicine, Pinnacle Health Hospitals Hematology/Oncology Fellowship, Penn State Cancer Institute, Penn State Health Milton S. Hershey Medical Center Research Interests My clinical and research interests lie primarily in the field of genitourinary (GU) tumors, developing novel therapeutic combinations and biomarkers for GU cancer of the bladder, kidney and prostate. I have a keen interest in developing novel combination... Read More
May 2, 2018: A Big Ten Cancer Research Consortium study, led by investigators at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, could help determine whether an investigational combination of chemotherapy drugs might lead to improved overall responses in patients with metastatic or advanced unresectable gastric/gastroesophageal junction cancer. The goal of the single-arm, phase II study, known as BTCRC-GI15-015, is to estimate the overall objective response rate in subjects receiving the combination of FOLFOX and nab-paclitaxel (FOLFOX-A). Read More
May 1, 2018: The Big Ten Cancer Research Consortium will host meetings for the Big Ten CRC Foundation, Cancer Center Directors, Steering Committee, and Clinical Trial Working Groups during ASCO 2018. Read More
April 16, 2018: Every month, we huddle for another edition of Across the Consortium to recap the progress of our member institutions. Here are this month's hand-picked highlights from across the consortium! Be inspired as you catch all the action. Read More
April 14, 2018: As stated in the American Cancer Society’s Cancer Facts & Figures, in 2018, there will be an estimated 1,735,350 new cancer cases diagnosed and 609,640 cancer deaths in the United States. While cancer treatments and early detection have become more and more promising over the years – thus increasing life expectancy and lowering the mortality rate of cancer patients – prevention remains one of the most important challenges. Read More
March 25, 2018: Across the Consortium is your instant replay of Big Ten CRC member news. This month we highlight colon cancer screen options and advice; advancements in technology to provide better understanding of cancer spread; new strategy for treating pancreatic cancer; cutting edge cell therapies; and more! Read More
March 5, 2018: What do plant molecular biologists, chemical engineers, veterinarians, biomedical engineers, and analytical chemists from around the world have in common? Everything - at Purdue University - including correlative cancer research. "We work with people across campus and across the state that need our particular technical expertise," says Jill Hutchcroft, PhD, director of Purdue's Flow Cytometry and Cell Separation Facility. Purdue researchers in Dr. Jill Hutchcroft's lab"Our samples come from engineers, biologists, and chemists; our technology bridges many disciplines as people are trying to cross boundaries," says Hutchcroft. "We are really a connection between many different disciplines. We work with everything from human tumors to zebra fish to corn, and we work with many model systems. Our work... Read More
Subscribe to the Big Ten CRC Newsletter
X
Facebook
YouTube